145 related articles for article (PubMed ID: 9237802)
21. Anti-BSA antibodies do not cross-react with the 69-kDa islet cell autoantigen ICA69.
Rønningen KS; Atrazhev A; Luo L; Luo C; Smith DK; Korbutt G; Rajotte RV; Elliott JF
J Autoimmun; 1998 Jun; 11(3):223-31. PubMed ID: 9693970
[TBL] [Abstract][Full Text] [Related]
22. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
[TBL] [Abstract][Full Text] [Related]
23. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.
Zarour HM; Maillere B; Brusic V; Coval K; Williams E; Pouvelle-Moratille S; Castelli F; Land S; Bennouna J; Logan T; Kirkwood JM
Cancer Res; 2002 Jan; 62(1):213-8. PubMed ID: 11782380
[TBL] [Abstract][Full Text] [Related]
24. Immune response to Toxoplasma gondii--analysis of suppressor T cells in a patient with symptomatic acute toxoplasmosis.
Yano A; Norose K; Yamashita K; Aosai F; Sugane K; Segawa K; Hayashi S
J Parasitol; 1987 Oct; 73(5):954-61. PubMed ID: 2958613
[TBL] [Abstract][Full Text] [Related]
25. Importance of donor-derived lymphocytes in the protection of pancreaticoduodenal or islet grafts from recurrent autoimmunity: a role for RT6+NKR-P1+ T cells.
Tori M; Ito T; Kitagawa-Sakakida S; Nozawa M; Matsuda H; Shirakura R
Transplantation; 2000 Jul; 70(1):32-8. PubMed ID: 10919571
[TBL] [Abstract][Full Text] [Related]
26. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
Moustakas AK; Papadopoulos GK
Am J Med Genet; 2002 May; 115(1):37-47. PubMed ID: 12116175
[TBL] [Abstract][Full Text] [Related]
27. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
28. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
Ablamunits V; Elias D; Reshef T; Cohen IR
J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
[TBL] [Abstract][Full Text] [Related]
29. Initial events and T cell activation in lymphokine-mediated allergic responses in patients with hen egg allergy.
Noma T; Yoshizawa I; Maeda K; Baba M; Yata J
Ann Allergy; 1994 Jul; 73(1):76-84. PubMed ID: 8030806
[TBL] [Abstract][Full Text] [Related]
30. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects.
Mustafa AS
Med Princ Pract; 2009; 18(5):385-92. PubMed ID: 19648762
[TBL] [Abstract][Full Text] [Related]
31. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
32. Immobilized staphylococcal enterotoxin A is sufficient to induce T cell proliferation.
Rust CJ; Koning F; van Schooten WC
Cell Immunol; 1993 Oct; 151(2):467-73. PubMed ID: 8402950
[TBL] [Abstract][Full Text] [Related]
33. In vitro effects of solubilized HLA-DR--role in immunoregulation?
Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein.
Puri J; Arnon R; Gurevich E; Teitelbaum D
J Immunol; 1997 Mar; 158(5):2471-6. PubMed ID: 9036999
[TBL] [Abstract][Full Text] [Related]
35. T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma.
Lassalle P; Delneste Y; Gosset P; Gras-Masse H; Wallaert B; Tonnel AB
Eur J Immunol; 1993 Apr; 23(4):796-803. PubMed ID: 8458370
[TBL] [Abstract][Full Text] [Related]
36. HLA-DR binding analysis of peptides from islet antigens in IDDM.
Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
[TBL] [Abstract][Full Text] [Related]
37. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR-restricted T cell lines from newly diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: lack of reactivity to glutamic acid decarboxylase.
Huang GC; Tremble J; Bailyes E; Arden SD; Kaye T; McGregor AM; Banga JP
Clin Exp Immunol; 1995 Oct; 102(1):152-8. PubMed ID: 7554382
[TBL] [Abstract][Full Text] [Related]
39. Borrelia burgdorferi--specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis.
Martin R; Ortlauf J; Sticht-Groh V; Bogdahn U; Goldmann SF; Mertens HG
Ann Neurol; 1988 Oct; 24(4):509-16. PubMed ID: 3266455
[TBL] [Abstract][Full Text] [Related]
40. T cell activation and anergy to islet cell antigen in type I diabetes.
Miyazaki I; Cheung RK; Gaedigk R; Hui MF; Van der Meulen J; Rajotte RV; Dosch HM
J Immunol; 1995 Feb; 154(3):1461-9. PubMed ID: 7822811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
